Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of pre-transplantation exposure to immunosuppressive agents on lung transplant outcomes in interstitial lung disease.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Same author

Interstitial lung disease pattern recognition on full high resolution computed tomography volume: Development and evaluation of a decision-support tool for less-experimented radiologists.

Diagnostic and interventional imaging·2026

Same author

Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.

Pulmonology·2026

Same author

Epithelial PCSK6 Promotes Proliferation and Decreases Collagen Deposition by Fibroblasts Potentially via MMP Activation.

International journal of molecular sciences·2026

Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026

Same author

Pulmonary Fibrosis Beyond the Lung: Adipose Tissue as a Systemic Modifier of Fibrotic Remodeling.

Diagnostics (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

[Organizing pneumonia].

Bruno Crestani¹, Camille Taillé, Raphaël Borie

¹Service de pneumologie A et radiologie, Laboratoire d'Anatomie Pathologique, Hôpital Bichat, F-75877 Paris Cedex 18, France. bruno.crestani@bch.aphp.fr

Presse Medicale (Paris, France : 1983)

|December 1, 2009

Summary

This summary is machine-generated.

Organizing pneumonia is a lung condition involving repair processes, characterized by fibroblastic buds. Cryptogenic organizing pneumonia (COP) is a specific form sensitive to corticosteroids but prone to relapses.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Related Experiment Videos

Last Updated: Jun 18, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Area of Science:

Pulmonary Medicine
Pathology
Radiology

Background:

Organizing pneumonia is a pathological process in the lungs, signifying repair after injury.
It manifests histologically as fibroblastic buds in distal airways and alveoli.
Clinically, it presents as migratory alveolar opacities, often responsive to corticosteroids.

Purpose of the Study:

To define organizing pneumonia as both a pathological and clinical entity.
To describe the characteristics of cryptogenic organizing pneumonia (COP).
To outline the treatment response and relapse patterns associated with COP.

Main Methods:

Histopathological examination of lung tissue.
Radiographic and clinical assessment of patients.
Review of clinical contexts and potential causes of organizing pneumonia.

Main Results:

Organizing pneumonia involves fibroblastic proliferation in distal airways.
Clinical presentation includes migratory alveolar opacities.
High sensitivity to corticosteroids but frequent relapses upon dose reduction or cessation.

Conclusions:

Organizing pneumonia is a distinct clinicopathological entity.
Cryptogenic organizing pneumonia (formerly BOOP) requires histologic confirmation but is often diagnosed clinically.
COP exhibits characteristic treatment responses and relapse tendencies.